Strategies for local gene therapy of corneal allograft rejection

Research output: Contribution to journalArticle


Penetrating keratoplasty is the most common type of tissue transplant in humans. Irreversible immune rejection leads to loss of vision and graft failure. This complex immune response further predisposes future corneal transplants to rejection and failure. A diverse armamentarium of surgical and pharmacologic tools is available to improve graft survival. In this review, we will discuss the various gene therapeutic strategies aimed at potentiating the anterior chamber-associated immune deviation to extend graft survival.

Original languageEnglish (US)
Pages (from-to)11-25
Number of pages15
JournalMiddle East African Journal of Ophthalmology
Issue number1
Publication statusPublished - Jan 2013



  • Adenovirus
  • Corneal Transplant
  • Dendrimer
  • Gene Therapy
  • Immune Privilege
  • Neovascularization
  • Plasmid
  • Rejection

ASJC Scopus subject areas

  • Ophthalmology

Cite this